|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Thuermer, Maria; Gollowitzer, Andre; Pein, Helmut; Neukirch, Konstantin; Gelmez, Elif; Waltl, Lorenz; Wielsch, Natalie; Winkler, Rene; Loeser, Konstantin; Grander, Julia; Hotze, Madlen; Harder, Sonke; Doeding, Annika; Messner, Martina; Troisi, Fabiana; Ardelt, Maximilian; Schlueter, Hartmut; Pachmayr, Johanna; Gutierrez-Gutierrez, Oscar; Rudolph, Karl Lenhard; Thedieck, Kathrin; Schulze-Spaete, Ulrike; Gonzalez-Estevez, Cristina; Kosan, Christian; Svatos, Ales; Kwiatkowski, Marcel und Koeberle, Andreas
(2022):
PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling.
In: Nature Communications, Bd. 13, Nr. 1, 2982
Ahmad, Mubashir; Krueger, Benjamin Thilo; Kroll, Torsten; Vettorazzi, Sabine; Dorn, Ann-Kristin; Mengele, Florian; Lee, Sooyeon; Nandi, Sayantan; Yilmaz, Dilay; Stolz, Miriam; Tangudu, Naveen Kumar; Vazquez, David Carro; Pachmayr, Johanna; Cirstea, Ion Cristian; Spasic, Maja Vujic; Ploubidou, Aspasia; Ignatius, Anita und Tuckermann, Jan
(2022):
Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.
In: Bone Research, Bd. 10, Nr. 1, 33
Messner, Martina; Mandl, Melanie M.; Hackl, Mathias W.; Reinhardt, Till; Ardelt, Maximilian A.; Szczepanowska, Karolina; Fraedrich, Julian E.; Waschke, Jens; Jeremias, Irmela; Fux, Anja; Stahl, Matthias; Vollmar, Angelika M.; Sieber, Stephan A. und Pachmayr, Johanna
(2021):
Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers.
In: Scientific Reports, Bd. 11, Nr. 1, 11185
Messner, Martina; Schmitt, Sabine; Ardelt, Maximilian A.; Fröhlich, Thomas; Müller, Martin; Pein, Helmut; Huber-Cantonati, Petra; Ortler, Carina; König, Lars M.; Zobel, Lena; Koeberle, Andreas; Arnold, Georg J.; Rothenfusser, Simon; Kiemer, Alexandra K.; Gerbes, Alexander L.; Zischka, Hans; Vollmar, Angelika M. und Pachmayr, Johanna
(2020):
Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma.
In: FASEB Journal, Bd. 34, Nr. 9: S. 11860-11882
Unzue, Andrea; Jessen-Trefzer, Claudia; Spiliotopoulos, Dimitrios; Gaudio, Eugenio; Tarantelli, Chiara; Dong, Jing; Zhao, Hongtao; Pachmayr, Johanna; Zahler, Stefan; Bernasconi, Elena; Sartori, Giulio; Cascione, Luciano; Bertoni, Francesco; Sledz, Pawel; Caflisch, Amedeo und Nevado, Cristina
(2020):
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors.
In: Rsc Medicinal Chemistry, Bd. 11, Nr. 6: S. 665-675
Ardelt, Maximilian A.; Fröhlich, Thomas; Martini, Emanuele; Müller, Martin; Kanitz, Veronika; Atzberger, Carina; Cantonati, Petra; Messner, Martina; Posselt, Laura; Lehr, Thorsten; Wojtyniak, Jan-Georg; Ulrich, Melanie; Arnold, Georg J.; König, Lars; Parazzoli, Dario; Zahler, Stefan; Rothenfusser, Simon; Mayr, Doris; Gerbes, Alexander; Scita, Giorgio; Vollmar, Angelika M. und Pachmayr, Johanna
(2019):
Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy.
In: Hepatology, Bd. 69, Nr. 1: S. 376-393
Gronauer, Thomas F.; Mandl, Melanie M.; Lakemeyer, Markus; Hackl, Mathias W.; Messner, Martina; Korotkov, Vadim S.; Pachmayr, Johanna und Sieber, Stephan A.
(2018):
Design and synthesis of tailored human caseinolytic protease P inhibitors.
In: Chemical Communications, Bd. 54, Nr. 70: S. 9833-9836
Merk, Henriette; Messer, Philipp; Ardelt, Maximilian A.; Lamb, Don C.; Zahler, Stefan; Müller, Rolf; Vollmar, Angelika M. und Pachmayr, Johanna
(2017):
Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMT.
In: Molecular Cancer therapeutics, Bd. 16, Nr. 11: S. 2329-2339